EPIRAX 5mg / 2.5mg dragees medication leaflet

A03CA02 chlordiazepoxide + clidinium bromide • Alimentary tract and metabolism | Antispasmodics in combination with psycholeptics | Synthetic anticholinergic agents in combination with psycholeptics

Chlordiazepoxide and clidinium bromide are used together to treat gastrointestinal disorders associated with anxiety, such as irritable bowel syndrome. Chlordiazepoxide is a benzodiazepine that reduces anxiety, while clidinium bromide is an anticholinergic that helps relax the smooth muscles of the gastrointestinal tract.

This combination is taken orally, usually in capsule form, and should be used as directed by your doctor. It is important not to exceed the prescribed dose to avoid adverse effects.

Side effects may include drowsiness, dizziness, dry mouth, or constipation. In rare cases, severe allergic reactions or other complications may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as glaucoma or prostate enlargement, as these may affect the safety of this combination.

General data about EPIRAX 5mg / 2.5mg

Substance: chlordiazepoxide + clidinium bromide

Date of last drug list: 01-07-2020

Commercial code: W44062001

Concentration: 5mg / 2.5mg

Pharmaceutical form: dragees

Quantity: 30

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).